Note 8 - Stockholders' Equity: (Tables)

9 Months Ended

Mar. 31, 2014

Stockholders' Equity Note [Abstract]

Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]

	Weighted Average, March 31, 2014		Range, March 31, 2014			Weighted Average, March 31, 2013		Range, March 31, 2013
Volatility		49%	49%	-	50%		66%	60%	-	68
Dividend yield		-		-			-		-
Risk-free interest rate		0.62%	0.59%	-	0.68%		0.32%	0.31%	-	0.34
Expected term (years)		2.68	2.63	-	2.71		3.05	2.66	-	3.25

Schedule of Share-based Compensation, Stock Options, Activity [Table Text Block]

	Options			Weighted- Average Exercise Price		Weighted- Average Remaining Contractual Life		Aggregate Intrinsic Value
Outstanding at July 1, 2013		5,261,145		$	2.84		4.0	$	168,750
Granted		67,725			1.51
Expired		(900,000	)		2.84
Forfeited		(200,000	)		3.00
Exercised		-			-
Outstanding at March 31, 2014		4,228,870		$	2.82		3.4	$	-
Exercisable at March 31, 2014		4,228,870		$	2.82		3.4	$	-

Schedule of Nonvested Share Activity [Table Text Block]

	Options			Weighted Average Grant-Date Fair Value
Nonvested at July 1, 2013		325,000		$	1.86
Granted		67,725			0.51
Vested		(192,725	)		(1.15	)
Forfeited		(200,000	)		(2.10	)
Nonvested at March 31, 2014		-		$	-

Schedule of Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Table Text Block]

	Three months ended March 31, 2014		Three months ended March 31, 2013		Nine months ended March 31, 2014			Nine months ended March 31, 2013
General and administrative:
Fair value of stock/warrant bonuses expensed	$	-	$	-	$	-		$	1,151,250
Fair value of stock issued to an employee		-		24,999		94,998			74,997
Change in fair value from modification of option terms		-		-		307,638			-
Fair value of stock options (credited)/expensed		-		44,889		(87,517	)		379,973
Total	$	-	$	69,888	$	315,119		$	1,606,220
Research and development:
Fair value of stock options (credited)/expensed	$	-	$	7,801	$	(135,939	)	$	25,826
Total	$	-	$	7,801	$	(135,939	)	$	25,826